Shotgun Mass Spectrometry-based Lipid Profiling in Chronic Inflammatory Diseases

CompletedOBSERVATIONAL
Enrollment

427

Participants

Timeline

Start Date

March 1, 2015

Primary Completion Date

March 1, 2021

Study Completion Date

March 1, 2021

Conditions
BiomarkerLipidInflammationCardiovascular DiseasesIschemic StrokeSystemic Lupus ErythematosusHealthy
Interventions
OTHER

Blood collection for lipid profiling by LC-MS

Blood withdrawal

All Listed Sponsors
collaborator

Hospital Santa Cruz, Centro Hospitalar de Lisboa Ocidental

UNKNOWN

collaborator

Department of Neurology, Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental

UNKNOWN

collaborator

Hospital Dr. Fernando da Fonseca

UNKNOWN

collaborator

Lipotype GmbH, Tatzberg 47, 01307, Dresden, Germany.

UNKNOWN

collaborator

iNOVA4Health, CEDOC, NOVA Medical Schoo

UNKNOWN

collaborator

Fundação para a Ciência e a Tecnologia (FCT)

UNKNOWN

lead

Universidade Nova de Lisboa

OTHER

NCT04786431 - Shotgun Mass Spectrometry-based Lipid Profiling in Chronic Inflammatory Diseases | Biotech Hunter | Biotech Hunter